Read + Share
Amedeo Smart
Independent Medical Education
Papazoglou D, Wang XV, Shanafelt TD, Lesnick CE, et al. Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial. Blood 2024;143:57-63.PMID: 37824808
Email
LinkedIn
Facebook
Twitter
Privacy Policy